2022 Financial Outlook and Strategic Framework
© 2022 Cigna
7/
RR
Delivered
strong
adjusted
revenue
growth and
delivered
on adjusted
EPS target
2021 accomplishments
Provided continued support for
clients, customers and communities
with increased access to COVID-19
testing, vaccinations and treatment
with "Community of Immunity" and
other initiatives
Was named a global industry leader
in corporate sustainability for the fifth
consecutive year on the Dow Jones
Sustainability Indices
Delivered on our original expectation
to achieve at least $20.00 of
adjusted EPS
Returned over $9B in capital to
shareholders, including $1.3B of
shareholder dividends and $7.7B of
share repurchases
7
Drove Evernorth adjusted earnings
growth of 8% over 2020, above our
long-term earnings growth target of
4% to 6%, and drove adjusted
revenue growth of 14% over 2020
Completed the acquisition of
MDLIVE and expanded partnerships
with organizations such as Prime
Therapeutics, Ginger, Oscar Health
and Honeysuckle Health
Announced the divestiture of our
international life, accident and
supplemental businesses in seven
countries as we focus on our global
health services portfolio; the
transaction is expected to close in
the second quarter of 2022, subject
to applicable regulatory approvals
and customary closing conditions
Cigna. 14View entire presentation